# Pharmacokinetic Evaluation of Intranasal and Intramuscular Naloxone in Healthy Volunteers

> **NCT02572089** · PHASE1 · COMPLETED · sponsor: **National Institute on Drug Abuse (NIDA)** · enrollment: 30 (actual)

## Conditions studied

- Drug Overdose
- Opioid-Related Disorders

## Interventions

- **DRUG:** Naloxone

## Key facts

- **NCT ID:** NCT02572089
- **Lead sponsor:** National Institute on Drug Abuse (NIDA)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2017-01-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02572089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02572089, "Pharmacokinetic Evaluation of Intranasal and Intramuscular Naloxone in Healthy Volunteers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02572089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*